Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.7
4.2
Journals
Microorganisms
Announcements
share announcement

Announcements

30 April 2025
Richard DiMarchi and Rolf Müller Share the 2024 Tu Youyou Award


We are pleased to announce that the 2024 Tu Youyou Award has been conferred upon Richard DiMarchi and Rolf Müller, in recognition of their significant contributions to natural products chemistry and medicinal chemistry.

2024 Tu Youyou Award Laureates

Richard DiMarchi
Indiana University, USA		 Prof. Richard DiMarchi is a Distinguished Professor of Chemistry and Gill Chair in Biomolecular Sciences at Indiana University, USA. He is a member of the National Academy of Medicine and the National Inventors Hall of Fame. Dr. DiMarchi is a former Group Vice President at Eli Lilly and later at Novo Nordisk. He is recognized for his contributions to the discovery and development of rDNA-derived Humulin®, Humalog®, rGlucagon®, and Forteo®. His academic research has broadened the understanding of glucagon and incretin physiology and pioneered the discovery of single-molecule multi-mechanism agonists for the treatment of diabetes and obesity. The central element to success has been the chemical vision and technology to install within single molecules simultaneous agonism at related G-protein coupled receptors, coupled to the counter-intuitive discovery that glucagon and GIP agonism could synergize the therapeutic efficacy of GLP-1. These peptides and their conceptual approach have transformed the management of excessive body weight to a condition comparable to how hypertension, adult-onset diabetes, and excess cholesterol are medicinally managed.
“Professor DiMarchi was recognized by the 2024 Tu Youyou Award Committee members as being an exceptional leader in the medicinal chemistry of peptides and proteins of natural origin, and as a pioneer in the field of chemical biotechnology. His very important discoveries have led to breakthroughs in new drugs related to the therapy of diabetes and obesity. He has been named as an inventor on a very large number of patents, and he has had initially a highly successful scientific and administrative career in industry, which was followed by over two decades in academia as a distinguished professor.”
—Prof. Dr. A. Douglas Kinghorn, Chair of the Award Committee
   

Rolf Müller
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany;
Helmholtz Centre for Infections Research (HZI), Germany;
Saarland University, Germany		 Prof. Rolf Müller is the Founding and Managing Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Professor of Pharmaceutical Biotechnology at Saarland University, Germany. Having received his training from the University of Bonn, he held research positions at the University of Washington, USA, and Braunschweig University of Technology, Germany, prior to his appointment as professor to Saarland University. His laboratory has dedicated itself to the exploration of bacterial natural-product biosynthetic pathways for more than 20 years and has extensive experience in working with myxobacteria and other microbial producer strains. Starting from the isolation and characterization of new microorganisms, the scope of work includes microbiology-, biotechnology-, bioinformatics-, and chemistry-based approaches to exploit these isolates as sources of new drugs with a special focus on novel anti-infectives. Müller and his team apply a variety of state-of-the-art analytical methods and biological assays to perform biological and chemical characterizations of the identified compounds. Prof. Müller has received several awards, including the prestigious Gottfried Wilhelm Leibniz Prize, the PHOENIX Pharmacy Research Award, the DECHEMA Prize, and the Inhoffen Medal, as well as being an elected member of acatech, Leopoldina, and the German Academy of Sciences and Literature.
“The 2024 Tu Youyou Award Committee members were highly impressed by the truly outstanding past and ongoing contributions of Professor Müller in both microbial natural products isolation chemistry and in biosynthesis, as well as in the development of lead compounds for their potential in treating human diseases, through his global connections with various major funding agencies. He is also a dedicated teacher who has trained numerous graduate students and postdoctoral fellows, and he has lectured on his research in countries all over the world.”
—Prof. Dr. A. Douglas Kinghorn, Chair of the Award Committee

The achievements of Richard DiMarchi and Rolf Müller highlight the transformative impact of natural products chemistry and medicinal chemistry. We congratulate them and invite the global academic community and public to join us in celebrating their significant contributions.

2024 Award Committee
Committee Chair:

Committee Members (listed in alphabetical order):

  • Prof. Angelo Fontana, University of Naples “Federico II”, Italy;
  • Prof. Binghe Wang, Georgia State University, USA;
  • Dr. Diana Pinto, University of Aveiro, Portugal;
  • Prof. Hideaki Kakeya, Kyoto University, Japan;
  • Dr. RuAngelie Edrada-Ebel, University of Strathclyde, UK;
  • Prof. Thomas Prisinzano, University of Kentucky, USA
  • Prof. Wei Li, University of Tennessee Health Science Center, USA.

About the Tu Youyou Award:
The 2024 Tu Youyou Award includes a total monetary prize of 100,000 Swiss Francs and a medal for each recipient. Established in 2016 to honor the pioneering spirit of Nobel laureate Tu Youyou, the Tu Youyou Award is an international award honoring exceptional scholars dedicated to the fields of natural products chemistry and medicinal chemistry.

For further information about the award and the winners, please visit the Tu Youyou Award website.

2 July 2025
MDPI INSIGHTS: The CEO's Letter #24 - 2024 Impact Factor & CiteScore, MDPI Summits France & USA, Tu Youyou Award

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI’s 2024 Impact Factor Highlights

For those of our readers who are new to academic publishing, you may have heard some news in June around the Impact Factor release. Every year, typically in June, Clarivate releases its annual Journal Citation Reports (JCR), which include Journal Impact Factors (JIF). This metric is widely used in academic publishing to reflect the average number of citations received by recent articles in each journal.

While Impact Factor is just one of many indicators of journal influence, it remains a major milestone for authors, editors, and publishers. It’s used to assess journal visibility, researcher recognition, and scholarly reach. Throughout our international meetings and events, it’s clear that the Impact Factor is something many of our authors and editorial board members care about, as it can influence where they choose to submit an article and the funding they receive for their research.

“These results reflect the trust that the scholarly community places in MDPI”

MDPI’s 2024 Impact Factor Highlights

  • 298 MDPI journals received a Journal Impact Factor.
  • 60 journals earned their first-ever Impact Factor
    • To put this in perspective: MDPI’s 60 new journal acceptances into the Web of Science was the second highest number of any publisher in 2024, behind Elsevier and ahead of Springer Nature. Our 87% acceptance rate for journals submitted to Web of Science shows the strength of our editorial process and our proven ability to develop journals aligned with Clarivate’s 24 evaluation criteria.
    • Notably, Textiles, Mathematics, International Journal of Neonatal Screening, Smart Cities, Systems, and Pharmaceutics ranked in the top 10% in their respective categories, highlighting their growing influence and prestige within their academic fields. This shows that high-quality indexing goes beyond visibility; it upholds credibility and trust.
  • 193 MDPI journals are now ranked in the top 50% (Q1/Q2) of their subject categories.
    • What does this mean, and why is it important? Journals are ranked by quartiles within their field, based on their Impact Factor. Q1 represents the top 25% of journals in their category, Q2 the next 25%, and so on. Being in Q1 or Q2 shows that a journal is performing well relative to other journals in its category. Authors and institutions often look at quartile rankings when choosing where to publish – it’s an important indicator of visibility and recognition, within its respective category.
  • 116 of our previously ranked journals increased their Impact Factor.
  • 14 MDPI journals achieved an Impact Factor of 5.0 or higher, suggesting a high degree of influence and visibility.

These results reflect our staff's hard work: from our editorial and production teams to our indexing, communications, and data teams, and beyond. This also reflects the trust that the scholarly community places in MDPI, reinforcing the message that when researchers publish with MDPI, they publish with impact.

Open Access with Impact

As the leading fully open access publisher, our journals have received a total of 18.4 million citations in the Web of Science by the end of 2024, reflecting the growing reach and engagement of research published with MDPI. We are committed to making scientific research freely accessible to everyone, everywhere. With the support of more than 4.2 million contributing authors, we’re proud to support the global shift toward open access.

Further Reading

If you’d like to better understand how journals get indexed and why Impact Factors matter, please read this recent interview with Dr. Constanze Schelhorn (Head of Indexing). It gives you a behind-the-scenes look at the role our indexing team plays in supporting journal indexing and visibility.

You can also read our official news announcement shared last week: MDPI Journals in the 2024 Journal Citation Reports.

Thank you to everyone, from our authors and reviewers to our editors and internal teams, who contributed to the progress of our journal indexing in 2024. We’re continuing to build journals that are recognized and trusted across disciplines.

Impactful Research

MDPI Journals See Continued Growth in 2024 CiteScore Results

Continuing our indexing updates, I’m pleased to share that MDPI has achieved strong results in the latest CiteScore metrics, released on 5 June by Scopus. These results reflect the collective efforts of our editors, reviewers, authors, and internal teams, with their dedication to quality and visibility in scientific publishing. You can read the full announcement here.

2024 Highlights:

  • 322 MDPI journals received a CiteScore (up from 274 last year).
  • 283 journals (88%) are ranked in Q1 or Q2 of their subject categories.
  • 237 journals (85%) saw an increase in their CiteScore compared to last year.
  • 48 journals received a CiteScore for the first time.
  • 39 journals are now placed in the top 10% of their subject areas.

“This growth highlights our commitment to supporting open, trusted science”

What is CiteScore and how is it measured?

CiteScore metrics are developed by Elsevier as an alternative to the Impact Factor. They measure the citation impact of journals and can be accessed freely on Scopus. The metric represents the yearly average number of citations to recent articles published in a journal. If you’re interested in learning more about citation metrics and how we use them, check out this blog post.

Why is this important?

These results show the growing recognition for, and impact of, MDPI journals across disciplines. CiteScore rankings help researchers, institutions, and funders assess where high-quality work is being published. This growth improves our journals’ positioning in the publishing landscape and highlights our commitment to supporting open, trusted science.

Inside MDPI

Highlights from the MDPI USA Summit in Boston (5–6 June)

With several Summits already behind us, I think this is a good time to reflect on the purpose of these Summits.

Why do we organize MDPI Summits?

These one-and-a-half-day, invite-only gatherings are designed to improve our relationships with Chief Editors who lead our journals and are respected voices in their fields. The Summits aim to:

  1. Share MDPI’s values, achievements, editorial practices, and local market collaborations.
  2. Collect feedback on MDPI operations and journal practices.
  3. Empower Chief Editors to confidently represent MDPI beyond the Summit.

While Chief Editors know their journals well, these events help them better understand MDPI. We want them to be ambassadors for our brand. The aim is for them to walk away informed, engaged, and equipped to share positively about MDPI.

About the Boston Summit

Held on 5–6 June, our first USA Summit gathered over 25 Chief Editors to learn more about MDPI’s activities and collaborations in the USA. The program included presentations, Q&A, and a panel discussion.

Agenda Highlights:

Moderated by Summer Huggard (Operations Manager [Toronto], MDPI), the program featured:

  • MDPI Overview and USA Collaboration – Stefan Tochev (CEO, MDPI)
  • AI in Publishing and MDPI's Actions – Feichi Lu (Junior Data Scientist, MDPI)
  • MDPI Editorial Process and Research Integrity – Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI)
  • Panel Discussion – Stefan, Feichi, Giulia, Claudia
  • Society Partnerships – Dr. Clàudia Aunós (Society Partnerships Senior Manager, MDPI)
  • Voice of the Customer and Closing Remarks – Stefan Tochev (CEO, MDPI)

MDPI & the USA: Facts and Figures

  • With over 216,000 publications, the USA is MDPI’s second-largest contributor after China.
  • In 2024, the USA ranked 2nd in total submissions and 2nd in total MDPI publications, with more than 28,200 publications.
  • As of 2020, the cumulative number of authors from the USA until April 2025 was 352,099.
  • As at April 2025, there are more than 12,035 active Editorial Board Members (EBMs) from the USA, with 55% having an H-index over 26.
  • Among them, 96 serve as Editors-in-Chief (EiC) and 218 as section-Editors-in-Chief (SEiC)
  • MDPI has more than 920 Institutional Open Access Program agreements worldwide, with over 130 from the USA.

A special thanks to our Toronto team, and everyone who worked behind the scenes to make this event run smoothly.

Coming Together for Science

Highlights from the MDPI France Summit in Paris (12–13 June)

We completed our first MDPI France Summit in Paris last week, and it was a special event. Attendees were engaged from beginning to end, remaining after hours to network and collaborate.

Why a France Summit?

We chose to host a France Summit in view of the recent challenges MDPI has faced with the National Centre for Scientific Research (CNRS). What we took away from the event is that our authors and editors very much appreciate and enjoy working with us, but we need to address the concerns raised by CNRS, around Article Processing Charges (APCs) and the funding of gold open access publications.

“Our authors and editors very much enjoy working with us”

Some of the claims made in the June 2023 interview with Alain Schuhl, the Deputy CEO for Science at the CNRS, are simply not factual. For example, they state that MDPI’s “average APC charges per article are now around the same as Springer Nature’s.” Here is the relevant passage, reproduced verbatim:

This is not accurate.

A recent preprint analysing APC data from Elsevier, Springer Nature, Wiley, PLOS, MDPI, and Frontiers (2019–2023) shows that MDPI’s average APCs remain significantly lower than those of Springer Nature and several other major publishers.

The MDPI Summits are part of our outreach and communication efforts to address misconceptions and clarify MDPI’s position as one of the most accessible and affordable major gold open access publishers in the world.

Summit Overview

Held on 12–13 June, the France Summit gathered over 20 Chief Editors to learn more about MDPI’s activities and collaborations in France. Many of these editors are influential in their institutions and professional societies. Several also have connections to CNRS, which makes this an important opportunity to clarify how we operate and build trust through open and transparent communication and hopefully turn our editors into informed advocates of MDPI.

Summit Feedback

The feedback has been very positive, with most attendees completing the post-event survey and all rating the experience as Excellent or Good. A few highlights:

  • “The whole thing was highly professional and, above all, provided quantified details that will allow us to better answer questions surrounding MDPI.”
  • “The summit was an opportunity to meet personally various people directly engaged in the organization and policies of MDPI, which made it possible to clarify some important points concerning publishing with MDPI.”
  • “Very well organized! A great opportunity to see all French MDPI partners and editors.”

Program Highlights:

Moderated by Miruna Adelina Nicolcioiu (Senior Conference Producer), the program featured:

  • MDPI Overview and France Collaboration – Stefan Tochev (CEO)
  • MDPI Editorial Process and Peer-Review Quality – Dr. Marta Colomer (Public Affairs Specialist)
  • Institutional Partnerships and Open Access Funding Models – Becky Castellon (Institutional Partnerships Manager)
  • AI in Publishing and MDPI's Actions – Daniele Raimondi (Data Scientist)
  • Publication Ethics: Global Trends – Diana Cristina Apodaritei (Research Integrity Specialist)
  • Closing Remarks – Stefan Tochev
  • Panel Discussion – Diana, Becky, Prof. Dr. Patrick Da Cost, and Stefan

MDPI & France: Facts and Figures

  • With over 51,000 publications, France is MDPI's tenth-largest contributor, and fifth largest among EU countries after Italy, Spain, Germany, and Poland.
  • As of 2020, the cumulative number of authors from France until April 2025 was 87,592.
  • As at April 2025, there are more than 2,800 active Editorial Board Members (EBMs) from France, with 59% having an H-index over 26.
  • Among them, 22 serve as Editors-in-Chief (EiC) and 61 as section-Editors-in-Chief (SEiC)
  • In 2024, IJMS, JCM, and Molecules were the top three MDPI journals in terms of submissions from French-affiliated authors.

Special thanks to our colleagues from Romanian offices for organizing this successful event.

Closing Thoughts

Richard DiMarchi and Rolf Müller Share the 2024 Tu Youyou Award

As we wrap up this month’s newsletter, I’d like to take a moment to recognize the winners of the 2024 Tu Youyou Award, presented by our journal Molecules. I am pleased to share that the 2024 Tu Youyou Award has been conferred upon Richard DiMarchi and Rolf Müller, in recognition of their significant contributions to natural products chemistry and medicinal chemistry.

I invite you to read the editorial co-authored by the Tu Youyou Award Committee, which highlights the significance of the award and the remarkable impact of the recipients’ research.

A sincere thank-you to the 2024 Award Committee for their dedication and selection process, and congratulations once again to this year’s honourees. Your work exemplifies the kind of research MDPI is proud to support and amplify.

About the Tu Youyou Award
The 2024 Tu Youyou Award includes a total monetary prize of 100,000 Swiss Francs and a medal for each recipient. Established in 2016 to honour the pioneering spirit of Nobel laureate Tu Youyou, the Tu Youyou Award is an international award recognizing exceptional scholars dedicated to the fields of natural products chemistry and medicinal chemistry.

For further information about the award and the winners, please visit the Tu Youyou Award website.
Stefan Tochev
Chief Executive Officer
MDPI AG

28 June 2025
Microorganisms | “Gut Microbiota” Section's Aims and Scope Update

To further enhance the quality of the Microorganisms’ Section, “Gut Microbiota”, and the papers published in it, under the guidance of our Section Editor-in-Chief, Dr. Pramod Gopal, the Section has updated and revised its Section Information and Keywords. The original scope and the updated version are listed below.

Section Information (new version):

Section Information (old version):

The gut microbiota, a complex community of trillions of microorganisms residing in the human gastrointestinal tract, plays a crucial role in maintaining overall health. It influences various bodily functions, including digestion, immune response, and even mental health through the gut–microbiota–brain axis. Over the last decade, it has become evident that the development of microbiota imbalance, known as dysbiosis, is linked to numerous health issues, such as inflammatory bowel disease, obesity, diabetes, and even neurological and psychological disorders. In addition, a balanced gut microbiota plays a role in supporting the absorption of nutrients and protection against pathogens.

With the advent of metagenomics, the composition of the microbiota has begun to be elucidated, and associations between the development of dysbiosis and alterations in microbiota composition can now be analyzed. The importance of specific bacterial species in the maintenance of a healthy microbiota and their roles in various physiological processes are also being increasingly understood. However, given the extremely broad range of metabolic functions across hundreds of species, a mechanistic understanding is key for detecting the actual functionalities of the different families and species in the consortia.

In animal hosts, the gut microbiota plays an equally crucial role in maintaining health. Studies of animal gut microbiota have provided important insights into microbial ecology and the interactions between the microbiota and the host. Significant attention has been paid to the gut microbiota of farm animals, with a focus on raising healthy animals, including investigations of the associations of the gut microbiota with improved feed conversion ratios and protection against pathogens. Similarly, the gut microbiota of companion animals and its associations with various health issues have attracted researchers' attention.

In the section “Gut Microbiota”, we focus on research questions related to microbial ecology within the community, the functionalities of microbiota members, metabolic and immunological interactions with the host (both human and animal), and the role of the gut microbiota in health and disorders. The Editorial Board will review all the manuscripts submitted for publication in this section; articles outside the scope of the subject matter listed here may be referred to another section of Microorganisms (ISSN: 2076-2607).

The symbiosis between the gut microbiota and the host depends on the metabolic and immunologic interaction with the host. Over the last ten years it has become evident that the development of a dysbiosis plays an important role in many diseases. These include metabolisms related diseases such as the metabolic syndrome, and diseases of the intestinal tract such as inflammatory bowel diseases, but there is also a gut–brain–axis that can be influenced by the intestinal microbiota.

With the advent of metagenomics, the question of the composition became addressable and associations between the development of a dysbiosis and an altered composition of the microbiota can now be analyzed. Given the extremely broad range of metabolic functions in the hundreds of species, a mechanistic understanding is key to detect the actual functionalities of the different families and species in the consortia.

In the section Gut Microbiota, we will focus on research questions aiming at the microbial ecology in the community, the functionalities of members of the microbiota, the metabolic and immunological interaction with the host and the role of the microbiota in human diseases. The editorial board will review all manuscripts submitted for publication in this section. However, articles which seem to be outside the scope of the subject matter listed here may be referred to another section of Microorganisms.

Keywords (new version):

Keywords (old version):
  • The structure and function of the microbiota;
  • Microbial community genetics, transcriptomics, proteomics, and metabolomics;
  • Interaction within the microbiota;
  • Metabolic interaction with the host;
  • Inflammatory diseases;
  • Interaction with the immune system;
  • Microbial biodegradation of nutrients and xenobiotics;
  • Microbial ecology;
  • Microbial functions in different habitats within the gut;
  • Metabolic flux analysis;
  • Model systems for studying microbiome biology;
  • Novel technologies for the analysis of the structure and function of the microbiota.
  
  • Structure and function of the microbiota
  • Microbial community genetics, transcriptomics, proteomics and metabolomics
  • Interaction within the microbiota
  • Metabolic interaction with the host
  • Inflammatory diseases
  • Interaction with the immune system
  • Microbial biodegradation of nutrients and xenobiotics
  • Microbial ecology
  • Microbial functions in the different habitats within the gut
  • Metabolic flux analysis
  • Analysis of functionalities by stable isotope probing (DNA, RNA and protein)
  • Model systems for studying microbiome biology
  • Novel technologies for the analysis of structure and function of the microbiota

For more detailed information, please visit the following link: https://www.mdpi.com/journal/microorganisms/sections/gut_microbiota.

Microorganisms Editorial Office

27 June 2025
Meet Us at the European Corrosion Congress, 7–11 September 2025, Stavanger, Norway


Conference: European Corrosion Congress
Date: 7–11 September 2025
Location: Stavanger, Norway

MDPI will be attending the upcoming European Corrosion Congress (EuroCorr 2025) as an exhibitor. This conference will be held in Stavanger, Norway, from 7 to 11 September 2025 and is organized by the Norwegian Corrosion Society and European Federation of Corrosion.

EuroCorr 2025 aims to explore all aspects of corrosion science, technology, and engineering. The main theme of the conference is “Joining Forces for Smart and Sustainable Solutions to Fighting Corrosion in Society”.

Its scope includes, but is not limited to, the following:

  • Corrosion mechanism and education;
  • Corrosion hazard in industrial environment;
  • Materials protection and corrosion prevention.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth #21 and answering any questions that you may have. For more information about this conference, please visit the following website: https://eurocorr2025.org/.

26 June 2025
Meet Us at the 12th Congress on Trends in Medical Mycology (TIMM-12), 19–22 September 2025, Bilbao, Spain


Conference: 12th Congress on Trends in Medical Mycology (TIMM-12)

Date: 19–22 September 2025

Location: Bilbao, Spain

We are delighted to announce that MDPI will serve as an exhibitor at the 12th Congress on Trends in Medical Mycology (TIMM-12), taking place from 19 to 22 September 2025 in collaboration with the European Confederation of Medical Mycology (ECMM) and the Spanish Association of Mycology (AEM).

TIMM-12 will cover new, fascinating insights into the biology of fungi, intriguing host–fungal interactions, updated diagnostic and therapeutic management approaches, changing dynamics in clinical epidemiology, and the emergence of antifungal resistance and newly discovered fungal pathogens. The scientific topics are designed to be applicable from bench to bed for basic scientists in medical mycology, medical mycologists, microbiologists, and a wide range of clinicians specialized in adult or pediatric infectious diseases, hematology, oncology, transplantation medicine and primary immunodeficiencies, critical care, dermatology, and immunology and all others with an interest in medical mycology. TIMM-12 will be an excellent opportunity for all participants to meet face-to-face with old friends and colleagues, make new friends, and establish new collaborations in medical mycology.

Serving as both a sponsor and exhibitor underscores MDPI’s unwavering support for the dissemination of high-impact research in medical mycology. Our participation in TIMM-12 highlights our mission to accelerate open access knowledge exchange and facilitate global scientific collaboration. Researchers attending the conference will have the opportunity to engage with representatives from the following MDPI journals, all of which publish pioneering work covering fungal research and related disciplines:

The following open access journals will be represented at the conference:

We cordially invite all attendees to visit our exhibition booth to discuss potential collaborations, explore publishing opportunities, and learn more about our open access initiatives. Our delegates are eager to meet you, address your inquiries, and support your contributions to the field.

For further details about TIMM-12, please visit the official conference website: https://www.timm2025.org/.

26 June 2025
Microorganisms Receives an Updated Impact Factor of 4.2


We are pleased to share that Microorganisms (ISSN: 2076-2607) was awarded an increased Impact Factor of 4.2 in the 2024 Journal Citation Reports™ released by Clarivate™ in June 2025. Microorganisms ranks in Q2 (46 among 163 titles) in the “Microbiology” category.

The 2024 Journal Impact Factor is calculated by dividing the number of citations received in 2024 to all publications in the journal from 2022 and 2023 by the total number of citable publications from those same years.

To learn more, visit our journal statistics website for detailed metrics or check out our main IF announcement for general information.

The support and dedication of all the editors, reviewers, authors, and readers are an integral part of the journal’s performance. We would like to take this opportunity to thank all of you who have contributed to the journal.

19 June 2025
Meet Us at the 2025 KoSFoST International Symposium and Annual Meeting, 2–4 July 2025, Gwangju, Republic of Korea


Conference: 2025 KoSFoST International Symposium and Annual Meeting (2025 KoSFoST)
Date: 2–4 July 2025
Location: Gwangju, Republic of Korea

MDPI will be attending the 2025 KoSFoST International Symposium and Annual Meeting as an exhibitor. This event will be held from 2 to 4 July 2025, and we welcome researchers from different backgrounds to visit our booth and discuss their latest research with us.

The Korean Society of Food Science and Technology (KoSFoST), founded in 1968, has been at the forefront of advancing food science in Korea. Through cutting-edge research, academic exchange, and industry collaboration, KoSFoST has played a pivotal role in shaping the future of food science and technology, enhancing the food industry, and improving dietary culture.

This year’s conference will be a landmark event, showcasing groundbreaking technologies and pioneering innovations that are redefining the future of the food industry. FoodTech is rapidly evolving into a transformative force, driving advancements that enhance efficiency, safety, and sustainability across the entire food value chain—from production to consumption.

The following MDPI journals will be represented:

  • Foods;
  • Microorganisms;
  • IJMS;
  • Nutraceuticals;
  • Processes.

If you are planning to attend this conference, please do not hesitate to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit the following website: https://www.kosfost.or.kr/abstract/2025_spring/.

11 June 2025
Microorganisms Receives an Increased CiteScore of 7.7


We are pleased to share that Microorganisms (ISSN: 2076-2607) has received an increased CiteScore of 7.7 in June 2025, an impressive achievement for a journal running in Volume 13.

Microorganisms’ CiteScore ranks as follows:

  • Q1 (32 out of 148) in the “Microbiology (medical)” category;
  • Q1 (46 out of 188) in the “Microbiology” category;
  • Q1 (21 out of 86) in the “Virology” category.

You can find more statistics on our website.

The current CiteScores measure the average number of citations within a journal over a four-year window (2021–2024). The Scopus database provides a comprehensive suite of metrics that support informed publishing strategies, research evaluation and enable benchmarking of journal performance.

This achievement reflects the collective efforts of our authors, reviewers, and editors. Together we will continue to track the progress of Microorganisms and its growing impact in microbiology research.

11 June 2025
Meet Us at the 2nd Southeast Asia Ticks and Tick-Borne Diseases Symposium, 28–29 August 2025, Singapore


Conference: 2nd Southeast Asia Ticks and Tick-borne Diseases Symposium

Date: 28–29 August 2025

Location: National University of Singapore, Singapore

Join us in Singapore for the 2nd Southeast Asia Ticks and Tick-borne Diseases Symposium from 28 to 29 August 2025! This symposium aims to connect leading experts, researchers, and professionals while encouraging collaboration and knowledge exchange on ticks and tick-borne diseases (TBDs) in Southeast Asia. By featuring novel insights into tick research, TBDs in Southeast Asia, and other related concepts, this event will provide a unique platform for networking and scientific exchange, fostering a sustainable research community across ASEAN countries. It will also offer young and/or emerging scientists the chance to engage with global experts in the field.

Seize this opportunity to connect, learn, and contribute to the future of tick and TBD research in Southeast Asia. Register now and be part of this growing regional initiative!

The following journals will represent MDPI at the conference:

If you are planning to attend, feel free to reach out and start a conversation with us at our booth. Our team looks forward to meeting you in person and answering any questions you may have. For more details about the symposium, please visit the following website: https://www.gevme.com/2nd-southeast-asia-ticks-and-tick-borne-diseases-symposium.

10 June 2025
Meet Us at the 52nd Annual Meeting & International Symposium (KMB 2025), 25–27 June 2025, Busan, Republic of Korea


Conference: KMB 2025 52nd Annual Meeting & International Symposium
Date: 25–27 June 2025
Location: BEXCO, Busan, Republic of Korea

Join us in Republic of Korea for KMB 2025 52nd Annual Meeting & International Symposium, from 25 to 27 June 2025!

This symposium brings together leading scientists, researchers, and industry professionals to advance knowledge and innovation in microbiology and biotechnology.

With a focus on future innovation in microbial research & genomics, biotechnology for health & nutrition, and synthetic biology & bioengineering, the event offers a dynamic platform for scientific exchange and collaboration.

Don’t miss this opportunity to connect, learn, and contribute to the future of microbiology and biotechnology research in the region.

Register now and be part of this exciting scientific community!

The following journals will represent MDPI at the conference:

If you are planning to attend, feel free to reach out and start a conversation with us. Our team looks forward to meeting you in person and answering any questions you may have. For more details about the symposium, please visit: https://www.kormb.or.kr/abstract/2025_spring/


Displaying Announcement 1-10 on page 1 of 27.
Go to page     1 2 3 4 5 chevron_right last_page
Back to TopTop